Drug Database
Back to search

France· FR:69668703

OTIPAX, solution pour instillation auriculaire

A medicinal product containing phénazone + chlorhydrate de lidocaïne, registered in France by BIOCODEX, on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedOTIPAX, solution pour instillation au…ATC—REGISTER NO.FR:69668703PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about phénazone + chlorhydrate de lidocaïneAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
PHÉNAZONE + CHLORHYDRATE DE LIDOCAÏNE
Manufacturer
BIOCODEX
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400932790661
    1 flacon(s) en verre jaune(brun) de 16 g avec embout(s) avec compte-gouttes polyéthylène acétate de polyvinyle
    EUR 1.88

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Phénazone + chlorhydrate de lidocaïne in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All phénazone + chlorhydrate de lidocaïne products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Bulgaria · Otipax, Дроплекс
  • Czechia · Otipax
  • Estonia · Finoten
  • United Kingdom (Northern Ireland) · Otigo
  • Hungary · Otipax
  • Lithuania · Finoten, Otipax
  • Luxembourg · Otipax
  • Latvia · Finoten, Otipax
  • Malta · Otipax
  • Romania · Otilerin, Otipax

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/54d86f2b-8250-4acc-b61d-907a0617e1a6
GET /v1/drugs/54d86f2b-8250-4acc-b61d-907a0617e1a6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "69668703",
  "date_amm": "1997-08-13",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "PHÉNAZONE + CHLORHYDRATE DE LIDOCAÏNE",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution pour instillation",
  "voies_administration": "auriculaire",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about phénazone + chlorhydrate de lidocaïne.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console